Literature DB >> 27388624

Correction: Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy.

Hélène Bonsang-Kitzis, Léonor Chaltier, Lisa Belin, Alexia Savignoni, Roman Rouzier, Anne-Sophie Hamy, Marie-Paule Sablin, Florence Lerebours, François-Clément Bidard, Paul Cottu, Xavier Sastre-Garau, Marick Laé, Jean-Yves Pierga, Fabien Reyal.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0144359.].

Entities:  

Year:  2016        PMID： 27388624      PMCID： PMC4936688          DOI： 10.1371/journal.pone.0159123

Source DB:  PubMed          Journal:  PLoS One        ISSN： 1932-6203            Impact factor:   3.240


Dr. Anne-Sophie Hamy should be included in the byline as the sixth author. Her affiliations are 6: Residual Tumor and Response to Treatment Lab, Translational Research Department, Institut Curie, Paris, France, and 7: UMR932 Immunity and Cancer, INSERM, Paris, France. The contributions of this author are as follows: Wrote the manuscript. The correct citation is: Bonsang-Kitzis H, Chaltier L, Belin L, Savignoni A, Rouzier R, Hamy AS, et al. (2015) Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy. PLoS ONE 10(12): e0144359. doi:10.1371/journal.pone.0144359
  1 in total

1.  Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy.

Authors:  Hélène Bonsang-Kitzis; Léonor Chaltier; Lisa Belin; Alexia Savignoni; Roman Rouzier; Marie-Paule Sablin; Florence Lerebours; François-Clément Bidard; Paul Cottu; Xavier Sastre-Garau; Marick Laé; Jean-Yves Pierga; Fabien Reyal
Journal:  PLoS One       Date:  2015-12-18       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.